<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35169700</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2632-1297</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Brain communications</Title><ISOAbbreviation>Brain Commun</ISOAbbreviation></Journal><ArticleTitle>Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>fcab297</StartPage><MedlinePgn>fcab297</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">fcab297</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/braincomms/fcab297</ELocationID><Abstract><AbstractText>The nature and extent of persistent neuropsychiatric symptoms after COVID-19 are not established. To help inform mental health service planning in the pandemic recovery phase, we systematically determined the prevalence of neuropsychiatric symptoms in survivors of COVID-19. For this pre-registered systematic review and meta-analysis (PROSPERO ID CRD42021239750), we searched MEDLINE, EMBASE, CINAHL and PsycINFO to 20 February 2021, plus our own curated database. We included peer-reviewed studies reporting neuropsychiatric symptoms at post-acute or later time-points after COVID-19 infection and in control groups where available. For each study, a minimum of two authors extracted summary data. For each symptom, we calculated a pooled prevalence using generalized linear mixed models. Heterogeneity was measured with <i>I</i> <sup>2</sup>. Subgroup analyses were conducted for COVID-19 hospitalization, severity and duration of follow-up. From 2844 unique titles, we included 51 studies (<i>n&#x2009;</i>=&#x2009;18&#x2009;917 patients). The mean duration of follow-up after COVID-19 was 77 days (range 14-182 days). Study quality was most commonly moderate. The most prevalent neuropsychiatric symptom was sleep disturbance [pooled prevalence&#x2009;=&#x2009;27.4% (95% confidence interval 21.4-34.4%)], followed by fatigue [24.4% (17.5-32.9%)], objective cognitive impairment [20.2% (10.3-35.7%)], anxiety [19.1% (13.3-26.8%)] and post-traumatic stress [15.7% (9.9-24.1%)]. Only two studies reported symptoms in control groups, both reporting higher frequencies in COVID-19 survivors versus controls. Between-study heterogeneity was high (<i>I</i> <sup>2&#x2009;</sup>=&#x2009;79.6-98.6%). There was little or no evidence of differential symptom prevalence based on hospitalization status, severity or follow-up duration. Neuropsychiatric symptoms are common and persistent after recovery from COVID-19. The literature on longer-term consequences is still maturing but indicates a particularly high prevalence of insomnia, fatigue, cognitive impairment and anxiety disorders in the first 6 months after infection.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Badenoch</LastName><ForeName>James B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0002-6994-6916</Identifier><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rengasamy</LastName><ForeName>Emma R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Cameron</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakraborty</LastName><ForeName>Stuti</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Christian Medical College and Hospital, Vellore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundaram</LastName><ForeName>Ritika D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafeez</LastName><ForeName>Danish</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3712-136X</Identifier><AffiliationInfo><Affiliation>Homerton University Hospitals Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burchill</LastName><ForeName>Ella</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1674-8844</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Life Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saini</LastName><ForeName>Aman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical School, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Lucretia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cross</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>East Lancashire Hospitals NHS Trust, Lancashire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunt</LastName><ForeName>Camille K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Warwick Medical School, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conti</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ralovska</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sofia University 'St Kliment Ohridski', bul, 'Tsar Osvoboditel' 15, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Zain</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Edinburgh Medical School, College of Medicine and Veterinary Medicine, University of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollak</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-6171-0810</Identifier><AffiliationInfo><Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koychev</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michael</LastName><ForeName>Benedict D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holling</LastName><ForeName>Heinz</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Timothy R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Section of Cognitive Neuropsychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-4671-5410</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rooney</LastName><ForeName>Alasdair G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/J000914/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MRF_C0396</GrantID><Acronym>MRF</Acronym><Agency>MRF</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain Commun</MedlineTA><NlmUniqueID>101755125</NlmUniqueID><ISSNLinking>2632-1297</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">chronic COVID syndrome</Keyword><Keyword MajorTopicYN="N">neuropsychiatry</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35169700</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pii">fcab297</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu &#xa0;Y, Xu &#xa0;X, Chen &#xa0;Z, et al. &#xa0;Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. &#xa0;2020;87:18&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers &#xa0;JP, Chesney &#xa0;E, Oliver &#xa0;D, et al. &#xa0;Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. &#xa0;2020;7:611&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers &#xa0;JP, Watson &#xa0;C, Badenoch &#xa0;J, et al. &#xa0;Neurology and neuropsychiatry of COVID-19: A systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. J Neurol Neurosurg Psychiatry. &#xa0;2021;92(9):932-941.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083395</ArticleId></ArticleIdList></Reference><Reference><Citation>

Lokugamage &#xa0;A, Taylor &#xa0;S, Rayner &#xa0;C. Patients&#x2019; experiences of &#x201c;longcovid&#x201d; are missing from the NHS narrative. BMJ Opinion Blog. &#xa0;2020. Accessed 23 April 2021. https://blogs.bmj.com/bmj/2020/07/10/patients-experiences-of-longcovid-are-missing-from-the-nhs-narrative/</Citation></Reference><Reference><Citation>Alwan &#xa0;NA, Attree &#xa0;E, Blair &#xa0;J-M, et al. &#xa0;From doctors as patients: A manifesto for tackling persisting symptoms of Covid-19. BMJ. &#xa0;2020;370:m3565.</Citation><ArticleIdList><ArticleId IdType="pubmed">32933949</ArticleId></ArticleIdList></Reference><Reference><Citation>

Perego &#xa0;E, Callard &#xa0;F, Stras &#xa0;L, et al.  &#xa0;Why we need to keep using the patient made term &#x201c;Long Covid&#x201d;. BMJ Opinion Blog. &#xa0;2020. Accessed 23 April 2021. https://blogs.bmj.com/bmj/2020/10/01/why-we-need-to-keep-using-the-patient-made-term-long-covid/</Citation></Reference><Reference><Citation>Callard &#xa0;F, Perego &#xa0;E. How and why patients made Long Covid. Soc Sci Med. &#xa0;2021;268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh &#xa0;T, Knight &#xa0;M, A&#x2019;Court &#xa0;C, Buxton &#xa0;M., Husain &#xa0;L. &#xa0;Management of post-acute Covid-19 in primary care. BMJ &#xa0;2020; 370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence . COVID-19 rapid guideline: Managing the long-term effects of COVID-19 NICE guideline [NG188]. 2020. Accessed 23 April 2021. https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann &#xa0;VO, Carerj &#xa0;ML, Wieters &#xa0;I, et al. &#xa0;Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. &#xa0;2020;5:1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan &#xa0;F, Ye &#xa0;T, Sun &#xa0;P, et al. &#xa0;Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. &#xa0;2020;295:715&#x2013;721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n Casas &#xa0;G, Catal&#xe0; &#xa0;A, Carretero Hern&#xe1;ndez &#xa0;G, et al. &#xa0;Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. &#xa0;2020;183:71&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267236</ArticleId><ArticleId IdType="pubmed">32348545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto &#xa0;A, Cristillo &#xa0;V, Piccinelli &#xa0;SC, et al. &#xa0;Long-term neurological manifestations of COVID-19: Prevalence and predictive factors. MedRxiv. &#xa0;2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet &#xa0;M, Geddes &#xa0;JR, Husain &#xa0;M, Luciano &#xa0;S, Harrison &#xa0;PJ. 6-month neurological and psychiatric outcomes in 236&#x2005;379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. &#xa0;2021;8(5):416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis &#xa0;HE, Assaf &#xa0;GS, McCorkell &#xa0;L, et al. &#xa0;Characterizing Long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. &#xa0;2020;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>
NHS England . Long COVID patients to get help at more than 60 clinics. 2020. Accessed 23 April 2021. https://www.england.nhs.uk/2020/12/long-covid-patients-to-get-help-at-more-than-60-clinics/</Citation></Reference><Reference><Citation>Nabavi &#xa0;N. Long Covid: How to define it and how to manage it. BMJ. &#xa0;2020;370:m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon &#xa0;S, Wegman-Ostrosky &#xa0;T, Perelman &#xa0;C, et al. &#xa0;More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Res Sq. &#xa0;2021;11(1):16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen &#xa0;M, Manoharan &#xa0;L, Elkheir &#xa0;N, et al. &#xa0;Characterising long-term Covid-19: A rapid living systematic review. MedRxiv. &#xa0;2020.</Citation></Reference><Reference><Citation>Page &#xa0;MJ, McKenzie &#xa0;JE, Bossuyt &#xa0;PM, et al. &#xa0;The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. &#xa0;2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson &#xa0;JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. &#xa0;2021;110:914&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>

Butler &#xa0;M, Watson &#xa0;C, Rooney &#xa0;AG, et al.  &#xa0;The neurology and neuropsychiatry of COVID-19. JNNP Blog. &#xa0;2020. Accessed 23 April 2021. https://blogs.bmj.com/jnnp/2020/05/01/the-neurology-and-neuropsychiatry-of-covid-19/</Citation></Reference><Reference><Citation>Viechtbauer &#xa0;W. Conducting meta-analyses in R with the metafor Package. J Stat Softw. &#xa0;2010;36:1&#x2013;48.</Citation></Reference><Reference><Citation>Hamza &#xa0;TH, van Houwelingen &#xa0;HC, Stijnen &#xa0;T. The binomial distribution of meta-analysis was preferred to model within-study variability. J Clin Epidemiol. &#xa0;2008;61:41&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083461</ArticleId></ArticleIdList></Reference><Reference><Citation>Stijnen &#xa0;T, Hamza &#xa0;TH, &#xd6;zdemir &#xa0;P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. &#xa0;2010;29:3046&#x2013;3067.</Citation><ArticleIdList><ArticleId IdType="pubmed">20827667</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman &#xa0;MF, Tukey &#xa0;JW. Transformations related to the angular and the square root. Ann Math Stat. &#xa0;1950;21:607&#x2013;611.</Citation></Reference><Reference><Citation>Klein &#xa0;H, Asseo &#xa0;K, Karni &#xa0;N, et al. &#xa0;Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: A cohort study in Israeli patients. Clin Microbiol Infect. &#xa0;2021;27(5):769&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO Headquarters (HQ). COVID-19 Clinical management: Living guidance . 2021. Accessed 27 April 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1</Citation></Reference><Reference><Citation>De Lorenzo &#xa0;R, Conte &#xa0;C, Lanzani &#xa0;C, et al. &#xa0;Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS ONE. &#xa0;2020;15:e0239570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju &#xa0;Y, Chen &#xa0;W, Liu &#xa0;J, et al. &#xa0;Effects of centralized isolation vs. home isolation on psychological distress in patients with COVID-19. J Psychosom Res. &#xa0;2021;143:110365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816602</ArticleId><ArticleId IdType="pubmed">33581399</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani &#xa0;L, Ramezani &#xa0;M, Darazam &#xa0;IA, et al. &#xa0;Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. &#xa0;2021;27:154&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Niklassen &#xa0;AS, Draf &#xa0;J, Huart &#xa0;C, et al. &#xa0;COVID-19: Recovery from chemosensory dysfunction. A multicentre study on smell and taste. Laryngoscope. &#xa0;2021;131:1095&#x2013;1100.</Citation><ArticleIdList><ArticleId IdType="pubmed">33404079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni &#xa0;D, Bai &#xa0;F, Castoldi &#xa0;R, et al. &#xa0;Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy. J Med Virol. &#xa0;2021;93:1175&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada &#xa0;M, Moreno &#xa0;E, Cari&#xf1;ena &#xa0;A, et al. &#xa0;Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. &#xa0;2021;126:e110&#x2013;e113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan &#xa0;M, Soddu &#xa0;D, Balbo &#xa0;PE, et al. &#xa0;Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. &#xa0;2021;4:e2036142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh &#xa0;TK, Park &#xa0;HY, Song &#xa0;I-A. Risk of psychological sequelae among coronavirus disease-2019 survivors: A nationwide cohort study in South Korea. Depress Anxiety. &#xa0;2021;38:247&#x2013;254.</Citation></Reference><Reference><Citation>Miyazato &#xa0;Y, Morioka &#xa0;S, Tsuzuki &#xa0;S, et al. &#xa0;Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis. &#xa0;2020;7:ofaa507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665672</ArticleId><ArticleId IdType="pubmed">33230486</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang &#xa0;L, Yang &#xa0;B, Jiang &#xa0;N, et al. &#xa0;Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci. &#xa0;2020;35:e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber &#xa0;T, Sahanic &#xa0;S, Pizzini &#xa0;A, et al. &#xa0;Cardiopulmonary recovery after COVID-19&#x2014;An observational prospective multi-center trial. Eur Respir J. &#xa0;2020;57(4):2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues &#xa0;E, Janvier &#xa0;P, Kherabi &#xa0;Y, et al. &#xa0;Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. &#xa0;2020;81:e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar &#xa0;Y, Gaw &#xa0;SL, Flaherman &#xa0;VJ, et al. &#xa0;Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstet Gynecol. &#xa0;2020;136:1117&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7673633</ArticleId><ArticleId IdType="pubmed">33027186</ArticleId></ArticleIdList></Reference><Reference><Citation>He &#xa0;S, Tian &#xa0;J, Li &#xa0;X, et al. &#xa0;Positive RT-PCR test results in 420 patients recovered from COVID-19 in Wuhan: An observational study. Front Pharmacol. &#xa0;2020;11:549117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577046</ArticleId><ArticleId IdType="pubmed">33117157</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter &#xa0;F, Mannan &#xa0;A, Mehedi &#xa0;HMH, et al. &#xa0;Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes Metab Syndr. &#xa0;2020;14(6):2031&#x2013;2038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575434</ArticleId><ArticleId IdType="pubmed">33113469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;Y-M, Shang &#xa0;Y-M, Song &#xa0;W-B., et al. &#xa0;Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. &#xa0;2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Cruz &#xa0;RF, Waller &#xa0;MD, Perrin &#xa0;F, et al. &#xa0;Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. &#xa0;2021;7:00655-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun &#xa0;B, Tang &#xa0;N, Peluso &#xa0;MJ, et al. &#xa0;Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. &#xa0;2021;10:386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam &#xa0;MS, Ferdous &#xa0;MZ, Islam &#xa0;US, et al. &#xa0;Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health. &#xa0;2021;18:1453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;C, Huang &#xa0;L, Wang &#xa0;Y, et al. &#xa0;6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. &#xa0;2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez &#xa0;O, Merino &#xa0;E, Leon-Ramirez &#xa0;J-M, et al. &#xa0;Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. &#xa0;2021;82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin &#xa0;SJ, McIvor &#xa0;C, Whyatt &#xa0;G, et al. &#xa0;Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. &#xa0;2021;93:1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong &#xa0;Q, Xu &#xa0;M, Li &#xa0;J, et al. &#xa0;Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin Microbiol Infect. &#xa0;2021;27:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales-Castillo &#xa0;A, Garc&#xed;a de los R&#xed;os &#xa0;C, Mediavilla Garc&#xed;a &#xa0;JD. Persistencia de manifestaciones cl&#xed;nicas tras la infecci&#xf3;n COVID-19: Importancia del seguimiento. Med Cl&#xed;nica &#xa0;2021;156:35&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518172</ArticleId><ArticleId IdType="pubmed">33077167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs &#xa0;LG, Gourna Paleoudis &#xa0;E, Lesky-Di Bari &#xa0;D, et al. &#xa0;Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. &#xa0;2020;15:e0243882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher &#xa0;A, Balfanz &#xa0;P, Cornelissen &#xa0;C, et al. &#xa0;Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med. &#xa0;2020;174:106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold &#xa0;DT, Hamilton &#xa0;FW, Milne &#xa0;A, et al. &#xa0;Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. &#xa0;2021;76:399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem &#xa0;K, Ghanima &#xa0;W, Olsen &#xa0;MK, Gilboe &#xa0;HM, Einvik &#xa0;G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: A population-based cohort study. Thorax. &#xa0;2021;76:405&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen &#xa0;MS, Kristiansen &#xa0;MF, Hanusson &#xa0;KD, et al. &#xa0;Long COVID in the Faroe Islands: A longitudinal study among nonhospitalized patients. Clin Infect Dis. &#xa0;2021;11: e4058&#x2013;e4063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo &#xa0;P, Borsetto &#xa0;D, Fabbris &#xa0;C, et al. &#xa0;Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Neck Surg. &#xa0;2020;146:729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst &#xa0;B, Peters &#xa0;JB, Brink &#xa0;M, et al. &#xa0;Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis &#xa0;2021;73: e1089&#x2013;e1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider &#xa0;C, Laurent &#xa0;E, Lemaignen &#xa0;A, et al. &#xa0;Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. &#xa0;2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal &#xa0;S, Barnett &#xa0;J, Brill &#xa0;SE, et al. &#xa0;&#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. &#xa0;2021;76:396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza &#xa0;MG, De Lorenzo &#xa0;R, Conte &#xa0;C, et al. &#xa0;Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. &#xa0;2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellaud &#xa0;C, Grandmaison &#xa0;G, Hoa Phong &#xa0;PHT, et al. &#xa0;Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area&#x2014;a retrospective cohort study. Swiss Med Wkly. &#xa0;2020;150:w20314.</Citation><ArticleIdList><ArticleId IdType="pubmed">32662869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu &#xa0;Y, Li &#xa0;X, Geng &#xa0;D, et al. &#xa0;Cerebral micro-structural changes in COVID-19 patients &#x2013; an MRI-based 3-month follow-up study. EClinicalMedicine. &#xa0;2020;25:100484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu &#xa0;S, Gao &#xa0;Q, Yang &#xa0;L, et al. &#xa0;Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China. PLoS ONE. &#xa0;2020;15:e0243883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746260</ArticleId><ArticleId IdType="pubmed">33332386</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson &#xa0;KB, Rao &#xa0;M, Bonilla &#xa0;H, et al. &#xa0;Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: A cautionary tale during a global pandemic. Clin Infect Dis. &#xa0;2021;73(3):e826&#x2013;e829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes &#xa0;DL, Holdsworth &#xa0;L, Jawad &#xa0;N, et al. &#xa0;Post-COVID-19 symptom burden: What is Long-COVID and how should we manage it? &#xa0;Lung. &#xa0;2021;199(2):113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sar-van der Brugge &#xa0;S, Talman &#xa0;S, Boonman-de Winter &#xa0;LJM, et al. &#xa0;Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir Med. &#xa0;2021;176:106272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7701891</ArticleId><ArticleId IdType="pubmed">33302142</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend &#xa0;L, Dyer &#xa0;AH, Jones &#xa0;K, et al. &#xa0;Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. &#xa0;2020;15:e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu &#xa0;C, Hu &#xa0;X, Song &#xa0;J, et al. &#xa0;Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China. Clin Transl Med. &#xa0;2020;10:e52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300592</ArticleId><ArticleId IdType="pubmed">32508037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan &#xa0;N, Wang &#xa0;W, Gao &#xa0;Y, et al. &#xa0;Medium term follow-up of 337 patients with coronavirus disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China. Front Med. &#xa0;2020;7:373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347902</ArticleId><ArticleId IdType="pubmed">32719806</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai &#xa0;X, Hu &#xa0;X, Ekumi &#xa0;IO, et al. &#xa0;Psychological distress and its correlates among COVID-19 survivors during early convalescence across age groups. Am J Geriatr Psychiatry &#xa0;2020;28(10):1030&#x2013;1039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347493</ArticleId><ArticleId IdType="pubmed">32753338</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu &#xa0;D, Baumeister &#xa0;RF, Veilleux &#xa0;JC, et al. &#xa0;Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Res. &#xa0;2020;292:113297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7355324</ArticleId><ArticleId IdType="pubmed">32707218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang &#xa0;X, Xu &#xa0;H, Jiang &#xa0;H, et al. &#xa0;Clinical features and outcomes of discharged coronavirus disease 2019 patients: A prospective cohort study. QJM. &#xa0;2020;113:657&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313792</ArticleId><ArticleId IdType="pubmed">32442308</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; &#xa0;A, Bernabei &#xa0;R, Landi &#xa0;F. Persistent symptoms in patients after acute COVID-19. JAMA. &#xa0;2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Einvik &#xa0;G, Dammen &#xa0;T, Ghanima &#xa0;W, Heir &#xa0;T, Stavem &#xa0;K. Prevalence and risk factors for post-traumatic stress in hospitalized and non-hospitalized COVID-19 patients. Int J Environ Res Public Health. &#xa0;2021;18:2079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924607</ArticleId><ArticleId IdType="pubmed">33672759</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue &#xa0;JK, Franko &#xa0;NM, McCulloch &#xa0;DJ, et al. &#xa0;Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. &#xa0;2021;4:e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci &#xa0;R, Dini &#xa0;M, Groppo &#xa0;E, et al. &#xa0;Long-lasting cognitive abnormalities after COVID-19. Brain Sci. &#xa0;2021;11:235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn &#xa0;Z, Moola &#xa0;S, Lisy &#xa0;K, Riitano &#xa0;D, Tufanaru &#xa0;C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. &#xa0;2015;13:147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317388</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence.  &#xa0;Depression in adults: Recognition and management. 2009. https://www.nice.org.uk/guidance/cg90</Citation><ArticleIdList><ArticleId IdType="pubmed">31990491</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence.  Generalised anxiety disorder and panic disorder in adults: management. 2011. Accessed 28 April 2021. https://www.nice.org.uk/guidance/cg113</Citation><ArticleIdList><ArticleId IdType="pubmed">31961629</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery &#xa0;P, Dennis &#xa0;J. Cognitive behavioural interventions for sleep problems in adults aged 60+&#x2009;. Cochrane Database Syst Rev. &#xa0;2003(1):CD003161.</Citation><ArticleIdList><ArticleId IdType="pubmed">12535460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisson &#xa0;JI, Roberts &#xa0;NP, Andrew &#xa0;M, Cooper &#xa0;R, Lewis &#xa0;C. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev &#xa0;2013;2013(12):CD003388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6991463</ArticleId><ArticleId IdType="pubmed">24338345</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine &#xa0;M, van de Port &#xa0;I, Rietberg &#xa0;MB, van Wegen &#xa0;EEH, Kwakkel &#xa0;G. Exercise therapy for fatigue in multiple sclerosis. Cochrane Database Syst Rev &#xa0;2015;(9):CD009956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9554249</ArticleId><ArticleId IdType="pubmed">26358158</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams &#xa0;AC de C, Eccleston &#xa0;C, Morley &#xa0;S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. &#xa0;2012;11(11):CD007407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6483325</ArticleId><ArticleId IdType="pubmed">23152245</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans &#xa0;R, McAuley &#xa0;H, Harrison &#xa0;E, et al. &#xa0;Physical, cognitive, and mental health impacts of COVID-19 following hospitalisation&#x2014;a multi-centre prospective cohort study. Lancet Respir Med. &#xa0;2021;9:1275&#x2013;1287</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>